WHO/Europe has released an expert opinion on managing drug-resistant tuberculosis (DR-TB) in children and adolescents, supported by a commentary in the Lancet.
DR-TB is particularly dangerous, and many young people suffering with the disease are undiagnosed. It is estimated that in the WHO European Region, 2000 children under the age of 15 with TB remain undiagnosed each year, a figure that is believed to be higher in the 15–19 years age group.
Furthermore, of those infected, 14% have especially dangerous and hard-to-treat forms of TB. This raises the risk that those who are undiagnosed with DR-TB will unknowingly spread the disease to increased numbers of people.
The guidance is evidence-based and provides updates on recent scientific evidence, as well as region-specific clinical and public health recommendations on tackling DR-TB in children and adolescents.